Phase 3 Neuralgia Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Not Yet Recruiting
Phase 2Phase 3
A Phase IIb/III Clinical Study to Evaluate the Efficacy and Safety of APC101 in Patients with Postherpetic Neuralgia.
Postherpetic Neuralgia
Andros Pharmaceuticals Pty Ltd333 enrolled1 locationACTRN12625001044415
Recruiting
Phase 3
Evaluation of the Efficacy of Therapeutic Infiltrations of the Pudendal Nerve, Performed Under Neurostimulation on Pain, 1 Month After an Infiltration of Local Anaesthetic, in the Treatment of Pudendal Neuralgia.
Pudendal Neuralgia
Groupe Hospitalier Diaconesses Croix Saint-Simon60 enrolled1 locationNCT06872437